In this article, James Matera, DO, writes about a newer agent, finarenone, which is a nonsteroidal, selective mineralocorticoid receptor antagonist that can treat chronic kidney disease.
In this commentary, Dr James Matera, from CentraState Medical Center, discusses new research on the effects of fruit and vegetable intake on mortality in patients undergoing hemodialysis.
In this article, James Matera, DO, writes about the benefits of using SGLT2 inhibitors to treat patients with type 2 diabetes, chronic kidney disease, and cardiovascular disease, including how the use of...
In this article, James Matera, DO, talks about the importance of evaluating a patient’s estimated glomerular filtration rate and how an eGFR compares with actual GFR.
In this commentary, James Matera, DO, writes about the ESRD treatment choice model that started on January 1, 2021, as well as its importance to and implications for practitioners.
In this Top Papers column, James Matera, DO, writes about 3 important research papers that highlight new potential treatment options for patients with CKD and anemia, and those with CKD and cardiovascular...
